VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,235,166 | -32.1% | 2,481,957 | +0.2% | 0.00% | -100.0% |
| Q2 2023 | $28,348,207 | +87.1% | 2,475,826 | +26.0% | 0.00% | – |
| Q1 2023 | $15,147,683 | +27.0% | 1,964,680 | +0.5% | 0.00% | – |
| Q4 2022 | $11,926,549 | +6.2% | 1,955,172 | +3.1% | 0.00% | – |
| Q3 2022 | $11,229,000 | -4.5% | 1,896,814 | -4.7% | 0.00% | – |
| Q2 2022 | $11,760,000 | -19.9% | 1,989,887 | +3.2% | 0.00% | – |
| Q1 2022 | $14,689,000 | +161.6% | 1,927,787 | -7.0% | 0.00% | – |
| Q4 2021 | $5,616,000 | -1.3% | 2,072,045 | -4.2% | 0.00% | – |
| Q3 2021 | $5,689,000 | -36.5% | 2,162,874 | -0.3% | 0.00% | – |
| Q2 2021 | $8,958,000 | -22.5% | 2,168,973 | -11.6% | 0.00% | – |
| Q1 2021 | $11,558,000 | -33.1% | 2,453,912 | +1.5% | 0.00% | -100.0% |
| Q4 2020 | $17,285,000 | -27.9% | 2,417,651 | +7.6% | 0.00% | 0.0% |
| Q3 2020 | $23,984,000 | -16.3% | 2,247,796 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $28,663,000 | +34.7% | 2,271,288 | -2.3% | 0.00% | 0.0% |
| Q1 2020 | $21,273,000 | -27.1% | 2,324,935 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $29,198,000 | -4.1% | 2,093,048 | +18.3% | 0.00% | 0.0% |
| Q3 2019 | $30,440,000 | -28.9% | 1,768,709 | +12.5% | 0.00% | -50.0% |
| Q2 2019 | $42,787,000 | +60.6% | 1,571,862 | +12.9% | 0.00% | +100.0% |
| Q1 2019 | $26,638,000 | +104.8% | 1,391,775 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $13,007,000 | -42.5% | 1,383,760 | +15.6% | 0.00% | 0.0% |
| Q3 2018 | $22,640,000 | +7.0% | 1,196,594 | +10.5% | 0.00% | 0.0% |
| Q2 2018 | $21,164,000 | +18.9% | 1,083,152 | +14.4% | 0.00% | 0.0% |
| Q1 2018 | $17,797,000 | +12.7% | 947,095 | -0.4% | 0.00% | 0.0% |
| Q4 2017 | $15,785,000 | +9.3% | 950,902 | +35.6% | 0.00% | 0.0% |
| Q3 2017 | $14,436,000 | +274.0% | 701,099 | +62.8% | 0.00% | – |
| Q2 2017 | $3,860,000 | -30.2% | 430,765 | +3.2% | 0.00% | – |
| Q1 2017 | $5,529,000 | +13.6% | 417,571 | +9.3% | 0.00% | – |
| Q4 2016 | $4,868,000 | +16.9% | 382,124 | +10.3% | 0.00% | – |
| Q3 2016 | $4,163,000 | +21.2% | 346,585 | +10.9% | 0.00% | – |
| Q2 2016 | $3,436,000 | +1897.7% | 312,593 | +1487.3% | 0.00% | – |
| Q1 2016 | $172,000 | -56.3% | 19,693 | +9.6% | 0.00% | – |
| Q4 2015 | $394,000 | – | 17,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |